Imaging sensitivity of dedicated positron emission mammography in relation to tumor size

Breast

Volumn 21, Issue 1, 2012, Pages 66-71

  Eo, Jae Seon ^a,b   Chun, In Kook ^a   Paeng, Jin Chul ^a   Kang, Keon Wook ^a   Lee, Sang Mi ^a   Han, Wonshik ^a   Noh, Dong Young ^a   Chung, June Key ^a   Lee, Dong Soo ^a,c  

^a Seoul National University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Breast cancer; PET; Positron emission mammography; Sensitivity

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CARCINOMA; BREAST EXAMINATION; BREAST SURGERY; CANCER CLASSIFICATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOMAMMOGRAPHY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; POSITRON EMISSION MAMMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME; WHOLE BODY PET;

EID: 84856328477     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2011.08.002     Document Type: Article

References (16)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Feig S. Cost-effectiveness of mammography, MRI, and ultrasonography for breast cancer screening. Radiol Clin North Am 2010, 48:879-891.
3. Berg W.A., Blume J.D., Cormack J.B., Mendelson E.B., Lehrer D., Böhm-Vélez M., et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 2008, 299:2151-2163.
4. Berg W.A., Blume J.D., Adams A.M., Jong R.A., Barr R.G., Lehrer D.E., et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology 2010, 254:79-87.
5. Escalona S., Blasco J.A., Reza M.M., Andradas E., Gomez N. Asystematic review of FDG-PET in breast cancer. Med Oncol 2010, 27:114-129.
6. Lim H.S., Yoon W., Chung T.W., Kim J.K., Park J.G., Kang H.K., et al. FDG PET/CT for the detection and evaluation of breast diseases: usefulness and limitations. Radiographics 2007, 27(Suppl 1):S197-S213.
7. Avril N., Adler L.P. F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging. Radiol Clin North Am 2007 Jul, 45:645-657.
8. MacDonald L., Edwards J., Lewellen T., Haseley D., Rogers J., Kinahan P. Clinical imaging characteristics of the positron emission mammography camera: PEM Flex Solo II. JNucl Med 2009, 50:1666-1675.
9. Berg W.A., Weinberg I.N., Narayanan D., Lobrano M.E., Ross E., Amodei L., et al. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J 2006, 12:309-323.
10. Levine E.A., Freimanis R.I., Perrier N.D., Morton K., Lesko N.M., Bergman S., et al. Positron emission mammography: initial clinical results. Ann SurgOncol 2003, 10:86-91.
11. Tafra L., Cheng Z., Uddo J., Lobrano M.B., Stein W., Berg W.A., et al. Pilot clinical trial of 18F-fluorodeoxyglucose positron-emission mammography in the surgical management of breast cancer. Am J Surg 2005, 190:628-632.
12. Schilling K., Narayanan D., Kalinyak J.E., The J., Velasquez M.V., Kahn S., et al. Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 2011, 38:23-36.
13. Berg W.A., Madsen K.S., Schilling K., Tartar M., Pisano E.D., Larsen L.H., et al. Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology 2011, 258:59-72.
14. Park S.A., Lee K.M., Choi U., Kim H.S., Kim H.W., Song J.H. Normal physiologic and benign foci with F-18 FDG avidity on PET/CT in patients with breast cancer. Nucl Med Mol Imaging 2010, 44:282-289.
15. Mavi A., Urhan M., Yu J.Q., Zhuang H., Houseni M., Cermik T.F., et al. Dual time point 18F-FDG PET imaging detects breast cancer with high sensitivity andcorrelates well with histologic subtypes. JNucl Med 2006, 47:1440-1446.
16. Caprio M.G., Cangiano A., Imbriaco M., Soscia F., Di Martino G., Farina A., et al. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions. Radiol Med 2010, 115:215-224.